Anteris Technologies reveals trials data of its aortic valve replacement

Brisbane medtech manufacturer Anteris Technologies has announced positive 12-month results from the first-in Human (FIH) study designed to evaluate the safety and efficacy of its DurAVR aortic valve replacement device (pictured) in patients with symptomatic severe aortic stenosis. DurAVR is a new class of aortic valve that utilises the company’s patented ADAPT anti-calcification process and…

New iLAuNCH Hub announces leadership appointments

The University of Southern Queensland-led Innovative Launch, Automation, Novel Materials, Communications and Hypersonics (iLAuNCH) Hub has announced leadership team appointments in the roles of COO, CTO and Executive Director. iLAuNCH was supported under the former Coalition federal government’s $362.5 million Trailblazer Universities initiative, with $50 million in federal funding announced in May before the election.…